Home/Filings/4/0001104659-22-005409
4//SEC Filing

Altarac David 4

Accession 0001104659-22-005409

CIK 0001724344other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:00 PM ET

Size

4.9 KB

Accession

0001104659-22-005409

Insider Transaction Report

Form 4
Period: 2022-01-18
Altarac David
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-01-18+125,000167,572 total
Footnotes (1)
  • [F1]This award vests over four years with twenty-five percent of the award vesting on each anniversary of the date of grant, subject to the reporting person's continued employment with the Company.

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001792615

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:00 PM ET
Size
4.9 KB